Fluorescence Guidance in Surgical Oncology: Challenges, Opportunities, and Translation

Madeline T. Olson, Quan P Ly, Aaron M Mohs

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Surgical resection continues to function as the primary treatment option for most solid tumors. However, the detection of cancerous tissue remains predominantly subjective and reliant on the expertise of the surgeon. Surgery that is guided by fluorescence imaging has shown clinical relevance as a new approach to detecting the primary tumor, tumor margins, and metastatic lymph nodes. It is a technique to reduce recurrence and increase the possibility of a curative resection. While significant progress has been made in developing this emerging technology as a tool to assist the surgeon, further improvements are still necessary. Refining imaging agents and tumor targeting strategies to be a precise and reliable surgical strategy is essential in order to translate this technology into patient care settings. This review seeks to provide a comprehensive update on the most recent progress of fluorescence-guided surgery and its translation into the clinic. By highlighting the current status and recent developments of fluorescence image-guided surgery in the field of surgical oncology, we aim to offer insight into the challenges and opportunities that require further investigation.

Original languageEnglish (US)
Pages (from-to)200-218
Number of pages19
JournalMolecular Imaging and Biology
Volume21
Issue number2
DOIs
StatePublished - Apr 15 2019

Fingerprint

Fluorescence
Neoplasms
Computer-Assisted Surgery
Technology
Optical Imaging
Patient Care
Lymph Nodes
Recurrence
Surgical Oncology
Surgeons
Therapeutics

Keywords

  • Fluorescence
  • Image-guided surgery
  • Optical contrast agents
  • Optical surgical navigation
  • Surgical oncology

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Fluorescence Guidance in Surgical Oncology : Challenges, Opportunities, and Translation. / Olson, Madeline T.; Ly, Quan P; Mohs, Aaron M.

In: Molecular Imaging and Biology, Vol. 21, No. 2, 15.04.2019, p. 200-218.

Research output: Contribution to journalReview article

@article{38c160a5c5214e13a104e7258c57aa2b,
title = "Fluorescence Guidance in Surgical Oncology: Challenges, Opportunities, and Translation",
abstract = "Surgical resection continues to function as the primary treatment option for most solid tumors. However, the detection of cancerous tissue remains predominantly subjective and reliant on the expertise of the surgeon. Surgery that is guided by fluorescence imaging has shown clinical relevance as a new approach to detecting the primary tumor, tumor margins, and metastatic lymph nodes. It is a technique to reduce recurrence and increase the possibility of a curative resection. While significant progress has been made in developing this emerging technology as a tool to assist the surgeon, further improvements are still necessary. Refining imaging agents and tumor targeting strategies to be a precise and reliable surgical strategy is essential in order to translate this technology into patient care settings. This review seeks to provide a comprehensive update on the most recent progress of fluorescence-guided surgery and its translation into the clinic. By highlighting the current status and recent developments of fluorescence image-guided surgery in the field of surgical oncology, we aim to offer insight into the challenges and opportunities that require further investigation.",
keywords = "Fluorescence, Image-guided surgery, Optical contrast agents, Optical surgical navigation, Surgical oncology",
author = "Olson, {Madeline T.} and Ly, {Quan P} and Mohs, {Aaron M}",
year = "2019",
month = "4",
day = "15",
doi = "10.1007/s11307-018-1239-2",
language = "English (US)",
volume = "21",
pages = "200--218",
journal = "Molecular Imaging and Biology",
issn = "1536-1632",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Fluorescence Guidance in Surgical Oncology

T2 - Challenges, Opportunities, and Translation

AU - Olson, Madeline T.

AU - Ly, Quan P

AU - Mohs, Aaron M

PY - 2019/4/15

Y1 - 2019/4/15

N2 - Surgical resection continues to function as the primary treatment option for most solid tumors. However, the detection of cancerous tissue remains predominantly subjective and reliant on the expertise of the surgeon. Surgery that is guided by fluorescence imaging has shown clinical relevance as a new approach to detecting the primary tumor, tumor margins, and metastatic lymph nodes. It is a technique to reduce recurrence and increase the possibility of a curative resection. While significant progress has been made in developing this emerging technology as a tool to assist the surgeon, further improvements are still necessary. Refining imaging agents and tumor targeting strategies to be a precise and reliable surgical strategy is essential in order to translate this technology into patient care settings. This review seeks to provide a comprehensive update on the most recent progress of fluorescence-guided surgery and its translation into the clinic. By highlighting the current status and recent developments of fluorescence image-guided surgery in the field of surgical oncology, we aim to offer insight into the challenges and opportunities that require further investigation.

AB - Surgical resection continues to function as the primary treatment option for most solid tumors. However, the detection of cancerous tissue remains predominantly subjective and reliant on the expertise of the surgeon. Surgery that is guided by fluorescence imaging has shown clinical relevance as a new approach to detecting the primary tumor, tumor margins, and metastatic lymph nodes. It is a technique to reduce recurrence and increase the possibility of a curative resection. While significant progress has been made in developing this emerging technology as a tool to assist the surgeon, further improvements are still necessary. Refining imaging agents and tumor targeting strategies to be a precise and reliable surgical strategy is essential in order to translate this technology into patient care settings. This review seeks to provide a comprehensive update on the most recent progress of fluorescence-guided surgery and its translation into the clinic. By highlighting the current status and recent developments of fluorescence image-guided surgery in the field of surgical oncology, we aim to offer insight into the challenges and opportunities that require further investigation.

KW - Fluorescence

KW - Image-guided surgery

KW - Optical contrast agents

KW - Optical surgical navigation

KW - Surgical oncology

UR - http://www.scopus.com/inward/record.url?scp=85049037629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049037629&partnerID=8YFLogxK

U2 - 10.1007/s11307-018-1239-2

DO - 10.1007/s11307-018-1239-2

M3 - Review article

C2 - 29942988

AN - SCOPUS:85049037629

VL - 21

SP - 200

EP - 218

JO - Molecular Imaging and Biology

JF - Molecular Imaging and Biology

SN - 1536-1632

IS - 2

ER -